Evidence map›Paper›PMID 27048822›Full record

ReviewCellular and molecular life sciences : CMLS2016

Mechanisms of ferroptosis.

Jennifer Yinuo Cao, Scott J Dixon

Open access · hybridAbstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 828 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
828citing papers in PubMed, 1 pooled it
47.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

828 citing papers in PubMed, 1 synthesis or guideline pooled it, 1,493 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Circular RNAs in ferroptosis regulation and tumor progression of gynecological and breast cancers: molecular mechanisms and therapeutic potential.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

768 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jennifer Yinuo CaoDepartment of Biology, Stanford University, 337 Campus Dr., Stanford, CA, 94305, USA.
Scott J DixonDepartment of Biology, Stanford University, 337 Campus Dr., Stanford, CA, 94305, USA. sjdixon@stanford.edu.
Stanford University · US

Funding

Targeting Tumor Cell Iron Addiction to Achieve Tumor-Selective Cell DeathR00CA166517 · NCI · STANFORD UNIVERSITY · PI DIXON, SCOTT · 2014 to 2016
$708k
NCI NIH HHS R00 CA166517
6 · The paper itself

Abstract

Ferroptosis is a non-apoptotic form of cell death that can be triggered by small molecules or conditions that inhibit glutathione biosynthesis or the glutathione-dependent antioxidant enzyme glutathione peroxidase 4 (GPX4). This lethal process is defined by the iron-dependent accumulation of lipid reactive oxygen species and depletion of plasma membrane polyunsaturated fatty acids. Cancer cells with high level RAS-RAF-MEK pathway activity or p53 expression may be sensitized to this process. Conversely, a number of small molecule inhibitors of ferroptosis have been identified, including ferrostatin-1 and liproxstatin-1, which can block pathological cell death events in brain, kidney and other tissues. Recent work has identified a number of genes required for ferroptosis, including those involved in lipid and amino acid metabolism. Outstanding questions include the relationship between ferroptosis and other forms of cell death, and whether activation or inhibition of ferroptosis can be exploited to achieve desirable therapeutic ends.

Indexed as

Cell DeathCell MembraneCyclohexylaminesFatty Acids, UnsaturatedGlutathioneGlutathione PeroxidaseIronNeoplasmsPhenylenediaminesPhospholipid Hydroperoxide Glutathione PeroxidaseQuinoxalinesReactive Oxygen SpeciesSpiro CompoundsCyclohexylaminesFatty Acids, Unsaturatedferrostatin-1GlutathioneGlutathione PeroxidaseIronliproxstatin-1PhenylenediaminesPhospholipid Hydroperoxide Glutathione PeroxidaseQuinoxalinesReactive Oxygen SpeciesSpiro CompoundsCancerCell deathErastinFerrostatin-1GlutathioneGlutathione peroxidase 4IronPolyunsaturated fatty acidRASReactive oxygen speciesSorafenib

Identifiers

PMID27048822
PMCPMC4887533
OpenAlexW2327686392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.